Systemic Lupus Erythematosus And Pregnancy
Keywords:
lupus erythematousus, systemic, pregnancy complications, maternal outcome, perinatal careAbstract
Systemic lupus erythematosus is an autoimmune disease of unknown etiology that preferentially affects women of reproductive age. Thus, its presence in the pregnancy-puerperal cycle is relatively frequent and has increased in recent decades. There is a risk of pregnancy on the disease, mainly due to hormonal changes at this stage of a woman's life, leading to reactivation of the disease; however, the risks of the disease on pregnancy are undoubtedly greater, in this case due to poor perinatal outcomes and a greater occurrence of maternal complications such as pre-eclampsia. Treatment of the disease during pregnancy must take into account both the risk of using immunosuppressive medication and the risk of disease activity. The follow-up of these cases must be multidisciplinary to achieve the best maternal and perinatal results.
Downloads
References
Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11 (5):352-6.
Carmona F, Font J, Cervera R, Munõz F, Cararach V, Balash J. Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999; 83:137-42.
Hochberg M. Updating the American College of Reumathology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 1997; 40(9): 1725.
Tan EM, Cohen AS, Fries JF , Masi AT, McShane DJ, Rothfield NF, et ai. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 2 5(11 ): 1271-7.
Mintz G, Niz J, Gutierrez G, et ai. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13:4.
Cunninghan FG, Gant NF, Leveno KJ, Gelstap LC, Hauth JC, Wenstom KD. Connective-tissue disorders. ln: Williams Obstetrics. 21th ed. New York: MacGraw-Hill; 2001.
Lockshin, MD. Pregnancy does not cause SLE to worsen. Arthritis Rheum 1989; 32:665.
Guballa N, Sammaritano L, Schwartzman S, et ai. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43:550.
Julkunen H, Kaaja R, Palosuo T, Gronhagen-Riska C, Teramo K. Pregnancy in lup.us nephropathy. Acta Obstet Gynecol Scand 1993; 72:258.
Bobrie G, Liote F, Houillier P, et ai. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987; 9:339.
Buyon JP, Tamerius J, Ordorica S, et ai. Activation of the alternative complement pathway accompanies disease fiares in systemic lupus erythematosus during pregnancy. Arthritis Rheum 1992; 35:55.
Repke JT. Hypertensive dis_orders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus. J Reprod Med 1998; 43:350.
Petri M, Albritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins lupus cohort. J Rheumatol 1993; 20:650.
Bermas BL, Shur, PH. Clinicai manifestation and diagnosis of the antiphospholipid antibody syndrome. Wellesley, MA: UpToDate®; ©2003 [cited 2004 Jun 16]. Available from:_http:// www.uptodate.com
Kutteh WH, Rote NS ,ilver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod lmmunol 1999; 41(2): 133-52.
Brucato A, 1Franceschini F, Buyon JP. Neonatal lupus: long-term outcomes of mothers and children and recurrence fate. Clin Exp Rheumatol 1997; 15:467
Buyon JP, Hiebert R, Cljlel J, Craft J, Friedman D, Katholi M, et ai. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1995; 31 (7): 1658-66.
Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius A. Serologic marker for fetal risk of congenital heart block.AL!_ MSO. Arthritis Rheum 2002; 46(5): 1233-41.
Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies.AU. Am J Med Genet 1999; 86(3):242-4.
Bonnie L, Bermas MD. Use of immunosuppressive drugs in pregnancy. Wellesley, MA: UpToDate; 2003 [cited 2004 Jun 16]. Available from: http://www.uptodate.com
Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantion 1994; 57(4):502-6.
Khamashta MA, Buchanan NM, Hughes GR. The use of hydroxychloroquine in lupus pregnancy: the British experience. Lup_us 1996; 5 Suppl > 1 :S65-6.
Seo P, Stone JH. Mycophenolate in the treatment of rheumatic diseases. Wellesley, MA: UpToDate; 2003 [cited 2004 Jun 16). Available from: http://wvvw.uptodate.com
